Tennessee SB0152 amends state law to allow patients with severe chronic diseases or terminal illnesses to access investigational stem cell treatments.

Tennessee SB0152 amends Tennessee Code to allow patients with severe chronic diseases or terminal illnesses to access investigational stem cell treatments. Patients must have a condition listed in rules adopted by the commissioner of health and must have exhausted all other FDA-approved treatment options. Physicians cannot face disciplinary action for recommending these treatments. The commissioner must develop informed consent forms, and governmental entities cannot interfere with a patient's access to these treatments.

Tennessee SB0152 amends state law to allow patients with severe chronic diseases or terminal illnesses to access investigational stem cell treatments.

Tennessee SB0152 amends Tennessee Code to allow patients with severe chronic diseases or terminal illnesses to access investigational stem cell treatments. Patients must have a condition listed in rules adopted by the commissioner of health and must have exhausted all other FDA-approved treatment options. Physicians cannot face disciplinary action for recommending these treatments. The commissioner must develop informed consent forms, and governmental entities cannot interfere with a patient's access to these treatments.